ID: ALA3889052
Type: Binding
Description: Inhibition Assay: Test compound is dissolved in DMSO 500× the highest final concentration desired in the IC50 assay. 30 ml of deionized water is pre-warmed to 37° C. and all kit components are placed on ice. For each well of column 1, 149.4 μL of NADPH-Cofactor Mix, (187.5 μl of Cofactors, 150 μl of G6PDH, 100 μl of Control Protein and 14.56 ml of 37° C. water) are added. In each well from Column 2 to 12, 100 μl of Cofactor/DMSO mix (40 μL DMSO in 9.96 ml of NADPH-Cofactor Mix) are added. To each well of column 1, 0.6 μl of test compound or positive control are added. 50 μl from each well of column 1 are serially diluted to column 8. The extra 50 μl from column 8 are discarded. The plate is covered and pre-incubated at 37° C. for 10 minutes. Preparation of enzyme/substrate mix: 7.92 ml of pre-warmed deionized water, 75 μl of enzyme, 3 μl of 10 mM AMMC and 2 ml of pre-warmed buffer are mixed. After the pre-incubation time (10'), 100 μl of enzyme/substrate mix to each well from column 1 to 10 are added. The plate is incubated at 37° C. for 30 minutes. After this time, 75 μl of Stop Reagent to each well are added. For blank controls, 100 μl of enzyme/substrate mix are added to columns 11 and 12.
Organism: Homo sapiens
Bioactivity
Activity Types for Assay ALA3889052
IC50
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
278.40 | 2.09 | 2.09 |
292.42 | 2.47 | 2.47 |
348.39 | 3.04 | 3.04 |
312.41 | 2.49 | 2.49 |
342.43 | 3.42 | 3.42 |
340.41 | 3.17 | 3.17 |
386.48 | 3.38 | 3.38 |
304.43 | 2.62 | 2.62 |
350.50 | 2.83 | 2.83 |
334.50 | 3.65 | 3.65 |
328.40 | 3.02 | 3.02 |
372.46 | 2.99 | 2.99 |
354.44 | 3.56 | 3.56 |
374.40 | 2.40 | 2.40 |
306.45 | 2.87 | 2.87 |
328.40 | 3.03 | 3.03 |
342.43 | 3.42 | 3.42 |
318.46 | 3.01 | 3.01 |
410.38 | 2.95 | 2.95 |
336.48 | 2.44 | 2.44 |
358.40 | 3.16 | 3.16 |
394.38 | 3.71 | 3.71 |
314.38 | 2.64 | 2.64 |
292.42 | 2.48 | 2.48 |
296.39 | 2.55 | 2.55 |
370.48 | 4.20 | 4.20 |
306.45 | 2.87 | 2.87 |